cholesterol Tag

An investigational cholesterol-reducing drug lowered patients’ levels of bad cholesterol by about 62 percent after six months, and halved their risk of premature death, stroke, and heart attack versus a placebo, researchers report. The drug, calledalirocumab, was developed by Sanofi, Paris, and Regeneron Pharmaceuticals Inc, Tarrytown, NY. The companies are encouraged by the findings, but say...

Although high cholesterol levels have long been associated with the incidence of breast cancer according to previous research studies, the chemical that causes the relationship has not been known until now. Drs. Donald McDonnell and Erik Nelson of Duke University have discovered a cholesterol metabolite that causes high cholesterol levels to precipitate the development and...